Outpatient pelvic inflammatory disease treatment as effective as inpatient care, study finds.
Levenson
Deborah
D
D000553:Ambulatory Care; D002440:Cefoxitin / Q000627:therapeutic use; D017046:Cost Savings; D004318:Doxycycline / Q000627:therapeutic use; D005260:Female; D006760:Hospitalization; D006801:Humans; D007246:Infertility / Q000209:etiology; D007297:Inpatients; D010045:Outpatients; D000292:Pelvic Inflammatory Disease / Q000150:complications / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011339:Probenecid / Q000627:therapeutic use; D011787:Quality of Health Care; D016032:Randomized Controlled Trials as Topic; D014481:United States
D002440:Cefoxitin; D004318:Doxycycline; D011339:Probenecid